KR850001905A - 벤조시클로 알칸 유도체의 제조방법 - Google Patents

벤조시클로 알칸 유도체의 제조방법 Download PDF

Info

Publication number
KR850001905A
KR850001905A KR1019840005180A KR840005180A KR850001905A KR 850001905 A KR850001905 A KR 850001905A KR 1019840005180 A KR1019840005180 A KR 1019840005180A KR 840005180 A KR840005180 A KR 840005180A KR 850001905 A KR850001905 A KR 850001905A
Authority
KR
South Korea
Prior art keywords
compound
coor
group
preparing
benzocyclo
Prior art date
Application number
KR1019840005180A
Other languages
English (en)
Other versions
KR910008349B1 (ko
Inventor
무네후미 가나오
Original Assignee
미야다께 가쥬오
다이이찌 세이야꾸 가부시기 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58155561A external-priority patent/JPS6048972A/ja
Priority claimed from JP10227884A external-priority patent/JPS60246380A/ja
Priority claimed from JP59112438A external-priority patent/JPS60255774A/ja
Priority claimed from JP12055784A external-priority patent/JPS611661A/ja
Priority claimed from JP59139525A external-priority patent/JPS6118770A/ja
Priority claimed from JP59147252A external-priority patent/JPH062745B2/ja
Application filed by 미야다께 가쥬오, 다이이찌 세이야꾸 가부시기 가이샤 filed Critical 미야다께 가쥬오
Publication of KR850001905A publication Critical patent/KR850001905A/ko
Application granted granted Critical
Publication of KR910008349B1 publication Critical patent/KR910008349B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/34—Monohydroxylic alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/62—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/36—Unsaturated compounds containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals

Abstract

내용 없음

Description

벤조시클로 알칸 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 일반식(Ⅱ)의 화합물을 이미다졸 또는 N－아실이미다졸과 반응시키고, 다음에 임의로는 생성된 화합물의 에스테르 잔기를 가수분해하거나 : 일반식(Ⅲ)의 화합물로 부터 아미노그룹을 제거하고, 다음에 임의로는 생성된 화합물의 에스테르 잔기를 가수분해하거나 : 일반식(Ⅳ)의 화합물을 축매적으로 환원하고, 다음에 임의로는 생성된 화합물의 에스테르 잔기를 가수분해함을 특징으로 하는 일반식(Ⅰ)의 화합물 또는 그의 생리학적으로 허용가능한 염을 제조하는 방법.
    상기식에서, Z는 메틸렌그룹 또는 에틸렌 그룹이고, R1과 R2중의 어느 하나는 －(CH2)m－COOR3이고, 다른 하나는
    또는
    (여기서, R3는 수소원자 또는 탄소수 1내지 6의 알킬그룹이고, n은 1내지 6의 정수이며, m은 0 내지 5의 정수이다)이고, R11과 R21중의 어느 하나는 －(CH2)m－COOR4이고 다른 하나는－(CH2)－X (여기서 X는 할로겐원자, 알킬설포닐옥시그룹 또는 아릴설포닐옥시 그룹이고, R4는 탄소수 1내지 6의 알킬그룹이다)이고, R12와 R22중의 어느 하나는 －(CH2)m－COOR4이고 다른 하나는이고, R13은 － (CH2)n 이고, R23은 －(CH2)m－COOR4이다.
  2. 제1항에 있어서, R1과 R2중의 어느 하나가 － (CH2)n 이고 다른 하나가 －(CH2)m－COOR3인 방법.
  3. 제1항에 있어서, R1과 R2중의 어느 하나가 － (CH2)n 이고, 다른 하나가 －(CH2)m－COOR3인 방법.
  4. 제1항에 있어서, R1이 －(CH2)n 이고 R2가 －(CH2)m－COOR3인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840005180A 1983-08-25 1984-08-25 벤조사이클로알칸 유도체를 제조하는 방법 KR910008349B1 (ko)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP58155561A JPS6048972A (ja) 1983-08-25 1983-08-25 テトラヒドロナフタレン誘導体
JP155561/83 1983-08-25
JP10227884A JPS60246380A (ja) 1984-05-21 1984-05-21 テトラヒドロナフタレン誘導体
JP102278/84 1984-05-21
JP59112438A JPS60255774A (ja) 1984-06-01 1984-06-01 テトラヒドロナフタレン誘導体
JP112438/84 1984-06-01
JP120557/84 1984-06-12
JP12055784A JPS611661A (ja) 1984-06-12 1984-06-12 ピリジン誘導体
JP139525/84 1984-07-05
JP59139525A JPS6118770A (ja) 1984-07-05 1984-07-05 テトラヒドロナフタレン誘導体
JP147252/84 1984-07-16
JP59147252A JPH062745B2 (ja) 1984-07-16 1984-07-16 インダン誘導体

Publications (2)

Publication Number Publication Date
KR850001905A true KR850001905A (ko) 1985-04-10
KR910008349B1 KR910008349B1 (ko) 1991-10-12

Family

ID=27552134

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840005180A KR910008349B1 (ko) 1983-08-25 1984-08-25 벤조사이클로알칸 유도체를 제조하는 방법

Country Status (9)

Country Link
US (2) US4665188A (ko)
EP (1) EP0135177B1 (ko)
KR (1) KR910008349B1 (ko)
AU (1) AU547979B2 (ko)
CA (1) CA1253866A (ko)
DE (1) DE3480652D1 (ko)
IE (1) IE58352B1 (ko)
PH (1) PH22076A (ko)
YU (1) YU43583B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508905A1 (de) * 1985-03-13 1986-09-18 Hoechst Ag, 6230 Frankfurt Neue imidazolylverbindungen und verfahren zu ihrer herstellung
EP0247089A1 (en) * 1985-10-30 1987-12-02 The Upjohn Company 3'-pyridinylalkylinden- and 3'-pyridinylalkylindol-2-carboxylic acids and analogs
IL86647A (en) * 1987-06-10 1992-02-16 Daiichi Seiyaku Co Pharmaceutical composition comprising 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid
IL86846A (en) * 1987-07-01 1992-03-29 Daiichi Seiyaku Co Pharmaceutical compositions for preventing and treating heart failure containing indane or naphthalene carboxylic acids
CA1314224C (en) * 1987-07-07 1993-03-09 Shinichiro Ashida Antidiabetic agent
US5166169A (en) * 1988-06-17 1992-11-24 Daiichi Pharmaceutical Co., Ltd. Treating agent for peripheral circulatory disturbances
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
ZA901416B (en) * 1989-02-27 1990-12-28 Daiichi Seiyaku Co Post-ptca restenosis inhibitor
US5354770A (en) * 1989-02-27 1994-10-11 Daiichi Pharmaceutical Co., Ltd. Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis
US5183886A (en) * 1989-05-22 1993-02-02 Mitsubishi Kasei Corporation Process for preparation of crystalline oxytitanium phthalocyanine showing A,B or C form
US5272264A (en) * 1989-05-22 1993-12-21 Mitsubishi Kasei Corporation Process for preparation of crystalline oxytitanium phthalocyanine
GB9027258D0 (en) * 1990-12-17 1991-02-06 Erba Carlo Spa Pyridyl derivatives of substituted bicyclic compounds and process for their preparation
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
US5344836A (en) * 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5559248A (en) * 1995-04-05 1996-09-24 Bristol-Myers Squibb Co. Retinoid-like heterocycles
US6559157B2 (en) 1997-10-02 2003-05-06 Daiichi Pharmaceutical Co., Ltd. Dihydronaphthalene compounds
DE69823222T2 (de) * 1997-10-02 2005-04-14 Daiichi Pharmaceutical Co., Ltd. Dihydronaphthalinderivate und verfahren zur herstellung derselben

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
CA1134828A (en) * 1978-12-28 1982-11-02 Tadao Tanouchi Pyridine derivatives
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
GB2122997B (en) * 1982-07-05 1985-08-14 Erba Farmitalia Imidazoles
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.

Also Published As

Publication number Publication date
DE3480652D1 (de) 1990-01-11
US4777257A (en) 1988-10-11
EP0135177B1 (en) 1989-12-06
YU43583B (en) 1989-08-31
AU547979B2 (en) 1985-11-14
US4665188A (en) 1987-05-12
EP0135177A2 (en) 1985-03-27
YU144784A (en) 1987-02-28
KR910008349B1 (ko) 1991-10-12
IE842170L (en) 1985-02-25
CA1253866A (en) 1989-05-09
EP0135177A3 (en) 1986-07-16
PH22076A (en) 1988-05-20
IE58352B1 (en) 1993-09-08
AU3238184A (en) 1985-02-28

Similar Documents

Publication Publication Date Title
KR850001905A (ko) 벤조시클로 알칸 유도체의 제조방법
KR840001156A (ko) 벤지미다졸 유도체의 제조방법
KR870004019A (ko) 퀴놀린 유도체의 제조방법
KR850004754A (ko) 3-인돌 카르복사미드 화합물류의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR840000557A (ko) 항균성 페넴 유도체
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR860001097A (ko) 4-아미노-2-페닐퀴놀린의 제조방법
KR830010106A (ko) 피페라진 유도체의 제조방법
KR890006620A (ko) 퀴놀린 유도체 및 그의 제조법
KR840001160A (ko) 벤조디옥산-이미다졸린 유도체의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR880000377A (ko) 트란스 헥사하이드로 테레프탈산 에스테르 유도체의 제조방법
KR890011830A (ko) 2-옥시이미노 -3- 옥소부티르산의 제조방법
KR910011845A (ko) 2-푸릴피리미딘 유도체의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR880000384A (ko) 안식향산 유도체의 제조방법
KR860003230A (ko) 피라졸 유도체의 제조 방법
KR890002176A (ko) 신규한 세펨 화합물
KR930004294A (ko) 퀴놀론 유도체의 제조 방법
KR850004098A (ko) 부타놀 유도체의 제조방법
KR840002848A (ko) 유기인산염의 제조방법
KR890016012A (ko) 2,4-디히드록시퀴놀린 유도체의 제조방법
KR850002975A (ko) 이미다졸린 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee